PPHM Headlines | Peregrine Pharmaceuticals Inc. Stock - Yahoo! Finance

Mon, May 20, 2013, 4:49PM EDT - U.S. Markets closed

Dow

0.12% Nasdaq

0.07%

More On PPHM

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM

1.83 0.29(18.83%) 4:00PM EDT|After Hours : 1.83 0.00 (0.00%) 4:31PM EDT

Add to Portfolio

Headlines

Get Headlines for:

Monday, May 20, 2013

Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trialsat Motley Fool (Mon 4:10PM EDT)
Small-cap makes a splash with FDA nod for cancer drugat MarketWatch (Mon 3:16PM EDT)
Movers roundup: WPX Energy, PeregrineAP (Mon 2:39PM EDT)
Why Peregrine Pharmaceuticals Shares Skyrocketedat Motley Fool (Mon 1:58PM EDT)
Peregrine rises on agreement for late-stage studyAP (Mon 1:15PM EDT)
Apple Explores OLED For Its Smartwatch and 2 Other Hot Stocks to Watchat Wall St. Cheat Sheet (Mon 12:58PM EDT)
Peregrine Pharma agrees with FDA on lung cancer trial designat Reuters (Mon 9:36AM EDT)
PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon 9:16AM EDT)
Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung CancerMarketwired (Mon 8:47AM EDT)
InPlay: Peregrine Pharma haltedBriefing.com (Mon 8:44AM EDT)

Thursday, May 16, 2013

Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual MeetingMarketwired (Thu, May 16)

Wednesday, May 8, 2013

Osiris Loss In-Line with ExpectationsZacks (Wed, May 8)
PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Wed, May 8)

Friday, May 3, 2013

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potentialat Seeking Alpha (Fri, May 3)

Monday, April 29, 2013

Is Peregrine Preparing to Soar Again?at Motley Fool (Mon, Apr 29)
4 Healthcare Stock Stories To Kick Off the Trading Weekat Wall St. Cheat Sheet (Mon, Apr 29)
Peregrine Announces Completion of Patient Enrollment in Breast Cancer Clinical Trial for BavituximabMarketwired (Mon, Apr 29)

Tuesday, April 23, 2013

Threshold: My Biotech Pick Of The Yearat Seeking Alpha (Tue, Apr 23)

Wednesday, April 10, 2013

4 Healthcare Stock Stories for Savvy Midweek Investmentat Wall St. Cheat Sheet (Wed, Apr 10)
Data Presented at AACR Annual Meeting Support Targeted Immune Reactivation Mechanism and Potential of Peregrine's Bavituximab in Solid Tumor TherapyMarketwired (Wed, Apr 10)

Older Headlines

Add PPHM News to My Yahoo!

Copyright © 2009 Yahoo! All rights reserved.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.